A detailed history of Salem Investment Counselors Inc transactions in Incyte Corp stock. As of the latest transaction made, Salem Investment Counselors Inc holds 779 shares of INCY stock, worth $54,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
779
Previous 779 -0.0%
Holding current value
$54,950
Previous $47,000 8.51%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 17, 2022

BUY
$66.18 - $83.18 $48,245 - $60,638
729 Added 1458.0%
779 $59,000
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $48,128 - $58,108
-729 Reduced 93.58%
50 $4,000
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $40,034 - $48,983
583 Added 297.45%
779 $54,000
Q2 2021

Aug 17, 2021

BUY
$79.87 - $87.53 $11,661 - $12,779
146 Added 292.0%
196 $16,000
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $3,159 - $4,298
-50 Reduced 50.0%
50 $4,000
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $7,304 - $9,572
100 New
100 $9,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.